Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soin Bio
Dayton, Ohio, United Statessointerapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Soin Therapeutics is a clinical-stage pharmaceutical company focused on developing novel treatments for chronic pain and rare diseases. The company's lead candidate, ST-2427, is a non-opioid, selective sodium channel inhibitor designed to treat conditions such as Complex Regional Pain Syndrome (CRPS) and erythromelalgia. By targeting specific sodium channels involved in pain signaling, Soin Therapeutics aims to provide effective analgesia without the addiction risks associated with opioids. The company is also exploring applications for its technology in post-operative pain management and other neuropathic pain conditions.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Soin Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Soin Bio.